Danilo D'Alessandro Clear Point Neuro, Inc. (CLPT) insider trading activity

Danilo D'Alessandro is Chief Financial Officer of ClearPoint Neuro, Inc.. Currently has a direct ownership of 70,746 shares of CLPT, which is worth approximately $931,724. The most recent transaction as insider was on Mar 12, 2025, when has been sold 8,284 shares (Common Stock) at a price of $13.18 per share, resulting in proceeds of $109,183. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.7K

42.94% 3M change

32.0% 12M change

Total Value Held $931,724

Danilo D'Alessandro Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2025	SELL Payment of exercise price or tax liability	$109,183 $13.18 p/Share	8,284 Reduced 10.48%	70,746 Common Stock
Mar 12 2025	BUY Exercise of conversion of derivative security	-	16,313 Added 17.11%	79,030 Common Stock
Mar 11 2025	SELL Payment of exercise price or tax liability	$26,746 $12.7 p/Share	2,106 Reduced 3.25%	62,717 Common Stock
Mar 11 2025	BUY Exercise of conversion of derivative security	-	4,146 Added 6.01%	64,823 Common Stock
Mar 06 2025	SELL Payment of exercise price or tax liability	$125,687 $13.19 p/Share	9,529 Reduced 13.57%	60,677 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	-	18,765 Added 21.09%	70,206 Common Stock
Dec 31 2024	BUY Grant, award, or other acquisition	$8,828 $4.53 p/Share	1,949 Added 3.65%	51,441 Common Stock
Aug 20 2024	SELL Payment of exercise price or tax liability	$13,410 $11.26 p/Share	1,191 Reduced 2.35%	49,492 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	$8,761 $4.58 p/Share	1,913 Added 3.64%	50,683 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$27,689 $5.74 p/Share	4,824 Reduced 9.0%	48,770 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$29,440 $6.24 p/Share	4,718 Reduced 8.09%	53,594 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	-	9,383 Added 13.86%	58,312 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$8,533 $5.77 p/Share	1,479 Added 2.93%	48,929 Common Stock
Sep 29 2023	SELL Payment of exercise price or tax liability	$24,839 $5.01 p/Share	4,958 Reduced 9.46%	47,450 Common Stock
Aug 20 2023	SELL Payment of exercise price or tax liability	$6,226 $5.34 p/Share	1,166 Reduced 2.18%	52,408 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$8,431 $6.15 p/Share	1,371 Added 2.5%	53,574 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$17,454 $6.91 p/Share	2,526 Reduced 4.62%	52,203 Common Stock
Sep 29 2022	SELL Payment of exercise price or tax liability	$50,720 $10.23 p/Share	4,958 Reduced 8.48%	53,477 Common Stock
Aug 20 2022	SELL Payment of exercise price or tax liability	$7,719 $13.24 p/Share	583 Reduced 0.99%	58,435 Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	23,400 Added 28.67%	58,214 Common Stock
Sep 29 2021	SELL Payment of exercise price or tax liability	$85,377 $17.22 p/Share	4,958 Reduced 12.9%	33,465 Common Stock
Aug 20 2021	BUY Grant, award, or other acquisition	-	5,875 Added 13.26%	38,423 Common Stock
Sep 29 2020	SELL Payment of exercise price or tax liability	$10,220 $5.8 p/Share	1,762 Reduced 5.14%	32,548 Common Stock
Sep 29 2020	BUY Grant, award, or other acquisition	-	4,310 Added 11.16%	34,310 Common Stock
Sep 29 2020	BUY Grant, award, or other acquisition	-	30,000 Added 50.0%	30,000 Common Stock

Danilo D'Alessandro

Chief Financial Officer

Solana Beach, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLPT shares.

Notify only if

Value

Insider Trading

Get notified when an Clear Point Neuro, Inc. insider buys or sells CLPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ClearPoint Neuro, Inc.

Track Activities on CLPT

Account